A 45-year-old woman with weight loss, tremor, and palpitations is found to have Graves disease. She presents with new-onset atrial fibrillation with rapid ventricular response (heart rate 150 beats/min) and no haemodynamic instability. According to good practice, what is the most appropriate immediate pharmacologic management?